← all drugs
Epinephrine Bitartrate, Lidocaine Hydrochloride Injection
in shortage · Anesthesia · Snapshot: 2026-10-09
Day 5,343
of this shortage, counting from the FDA's first posting on 02/22/2012
- Manufacturers listed
- Hospira, Inc., a Pfizer Company, Fresenius Kabi USA, LLC
- Reported reason(s)
- Other; Demand increase for the drug
- Machine-readable
- JSON for this drug
Presentations (22)
| Presentation | Company | Availability | Updated |
|---|---|---|---|
| Lidocaine Hydrochloride And Epinephrine, Injection, 400 mg/20 mL (2%; 1:100,000) (NDC 0409-3182-01) | Hospira, Inc., a Pfizer Company | Unavailable | 09/22/2026 |
| Lidocaine Hydrochloride And Epinephrine, Injection, 500 mg/50 mL (1%; 1:100,000) (NDC 0409-3178-03) | Hospira, Inc., a Pfizer Company | Limited Availability | 09/22/2026 |
| Xylocaine, Injection, .005 mg/1 mL; 5 mg/1 mL (NDC 63323-481-57) | Fresenius Kabi USA, LLC | Unavailable | 09/15/2026 |
| Lidocaine Hydrochloride And Epinephrine, Injection, 450 mg/30 mL (1.5%; 1:200,000) (NDC 0409-3181-01) | Hospira, Inc., a Pfizer Company | Available | 09/22/2026 |
| Xylocaine, Injection, .005 mg/1 mL; 15 mg/1 mL (NDC 63323-488-17) | Fresenius Kabi USA, LLC | Unavailable | 09/15/2026 |
| Xylocaine, Injection, .01 mg/1 mL; 20 mg/1 mL (NDC 63323-483-57) | Fresenius Kabi USA, LLC | Available | 10/06/2026 |
| Lidocaine Hydrochloride and Epinephrine, Injection, 600 mg/30 mL (2%; 1:100,000) (NDC 0409-3182-02) | Hospira, Inc., a Pfizer Company | Limited Availability | 09/22/2026 |
| Xylocaine, Injection, .01 mg/1 mL; 10 mg/1 mL (NDC 63323-482-17) | Fresenius Kabi USA, LLC | Available | 09/15/2026 |
| Xylocaine, Injection, .01 mg/1 mL; 10 mg/1 mL (NDC 63323-482-57) | Fresenius Kabi USA, LLC | Unavailable | 09/15/2026 |
| Xylocaine, Injection, .01 mg/1 mL; 20 mg/1 mL (NDC 63323-483-27) | Fresenius Kabi USA, LLC | Available | 10/06/2026 |
| Xylocaine, Injection, .005 mg/1 mL; 10 mg/1 mL (NDC 63323-487-37) | Fresenius Kabi USA, LLC | Available | 10/06/2026 |
| Xylocaine, Injection, .005 mg/1 mL; 15 mg/1 mL (NDC 63323-488-37) | Fresenius Kabi USA, LLC | Available | 10/06/2026 |
| Lidocaine Hydrochloride And Epinephrine, Injection, 1 g/50 mL (2%; 1:100,000) (NDC 0409-3182-03) | Hospira, Inc., a Pfizer Company | Limited Availability | 09/22/2026 |
| Xylocaine, Injection, .005 mg/1 mL; 10 mg/1 mL (NDC 63323-487-17) | Fresenius Kabi USA, LLC | Available | 10/06/2026 |
| Xylocaine, Injection, .01 mg/1 mL; 10 mg/1 mL (NDC 63323-482-27) | Fresenius Kabi USA, LLC | Available | 10/06/2026 |
| Lidocaine Hydrochloride And Epinephrine, Injection, 250 mg/50 mL (0.5%; 1:200,000) (NDC 0409-3177-01) | Hospira, Inc., a Pfizer Company | Unavailable | 09/22/2026 |
| Lidocaine Hydrochloride And Epinephrine, Injection, 300 mg/30 mL (1%; 1:100,000) (NDC 0409-3178-02) | Hospira, Inc., a Pfizer Company | Unavailable | 09/22/2026 |
| Xylocaine, Injection, .005 mg/1 mL; 20 mg/1 mL (NDC 63323-489-27) | Fresenius Kabi USA, LLC | Unavailable | 09/15/2026 |
| Xylocaine, Injection, .005 mg/1 mL; 20 mg/1 mL (NDC 63323-489-17) | Fresenius Kabi USA, LLC | Available | 10/06/2026 |
| Lidocaine Hydrochloride And Epinephrine, Injection, 400 mg/20 mL (2%; 1:200,000) (NDC 0409-3183-01) | Hospira, Inc., a Pfizer Company | Available | 09/22/2026 |
| Lidocaine Hydrochloride And Epinephrine, Injection, 75 mg/5 mL (1.5%; 1:200,000) (NDC 0409-1209-01) | Hospira, Inc., a Pfizer Company | Unavailable | 09/22/2026 |
| Lidocaine Hydrochloride And Epinephrine, Injection, 200 mg/20 mL (1%; 1:100,000) (NDC 0409-3178-01) | Hospira, Inc., a Pfizer Company | Unavailable | 09/22/2026 |
History
Daily tracking of this drug began 2026-08-25 (the first day of the archive).
- 2026-09-24 — Epinephrine Bitartrate, Lidocaine Hydrochloride Injection: availability wording revised for 1 presentation(s)
- 2026-09-17 — Epinephrine Bitartrate, Lidocaine Hydrochloride Injection: availability wording revised for 1 presentation(s)
- 2026-08-27 — Epinephrine Bitartrate, Lidocaine Hydrochloride Injection: availability wording revised for 5 presentation(s)
Each daily snapshot is compared with the one before it; status changes, availability-wording revisions, and arrivals or removals are listed here. A change the FDA makes and reverses between two snapshots is not seen. Every daily record is kept in the public repository.
Not medical advice. ShortSupply republishes the FDA's drug-shortage data with history added. Talk to your pharmacist or prescriber about your situation — never change medication based on this site.